ResMed Inc. (BIT:1RMD)

Market Cap	35.53B
Revenue (ttm)	4.38B
Net Income (ttm)	1.19B
Shares Out	n/a
EPS (ttm)	8.10
PE Ratio	29.79
Forward PE	25.89
Dividend	2.06 (0.88%)
Ex-Dividend Date	Aug 13, 2025

Volume	n/a
Average Volume	0
Open	235.70
Previous Close	235.70
Day's Range	235.70 - 235.70
52-Week Range	214.80 - 235.70
Beta	n/a
RSI	97.79
Earnings Date	Jul 31, 2025

About Augmedix

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1989
• Employees: 9,980
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1RMD

Financial Performance

In 2025, ResMed's revenue was $5.15 billion, an increase of 9.84% compared to the previous year's $4.69 billion. Earnings were $1.40 billion, an increase of 37.20%.